Prevalence of sarcopenia in inpatients 70 years and older using different diagnostic criteria.
Esmee M Reijnierse, Angela Buljan, Camilla S L Tuttle and 4 others
PMID 30918687WHAT IT FOUND
Sarcopenia prevalence in older hospital inpatients ranged widely by diagnostic criteria, from 12.0% to 75.9% in men and 3.1% to 75.3% in women.
The single strength-based criterion labelled 69.7% of men and 75.3% of women as sarcopenic.
Key findings
01Prevalence of sarcopenia varied by diagnostic criterion, ranging from 12.0% to 75.9% in men and from 3.1% to 75.3% in women.
02Using only muscle strength, 69.7% of men and 75.3% of women were classified as sarcopenic.
03Only 5 men and 1 woman were classified as sarcopenic by all applied diagnostic criteria.
STILL TO COME
How it was doneWhat they foundWhat it means for PTs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
The study was conducted at one university hospital, so its prevalence estimates may not apply to other inpatient populations. Fifty-seven patients were excluded from muscle mass measurements, so mass-based criteria were not applied in all included patients. Gait speed could not be measured at admission, so criteria requiring physical performance were not fully applied. Bioelectrical impedance measurements may have been affected by hydration status, which can change estimated muscle mass and fat mass. The diagnostic criteria were designed for the general population, not for inpatients, and no inpatient-specific criteria have been defined. The authors note that no healthcare professional is defined as responsible for measuring body composition and that nursing protocols have not been established. The study reports prevalence by diagnostic criteria only; it does not test whether identifying sarcopenia improves patient outcomes.
Declared interests
The authors report no conflicts of interest.
The easy way to misread this
Do not assume the high prevalence figures mean a valid inpatient sarcopenia diagnosis; they came from a single muscle-strength criterion, not a validated inpatient diagnosis. The study did not test treatment or outcomes.